130 related articles for article (PubMed ID: 17462692)
61. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains.
Candotti D; Grabarczyk P; Ghiazza P; Roig R; Casamitjana N; Iudicone P; Schmidt M; Bird A; Crookes R; Brojer E; Miceli M; Amiri A; Li C; Allain JP
J Hepatol; 2008 Oct; 49(4):537-47. PubMed ID: 18602718
[TBL] [Abstract][Full Text] [Related]
62. Molecular characterization of occult hepatitis B cases in Greek blood donors.
Katsoulidou A; Paraskevis D; Magiorkinis E; Moschidis Z; Haida C; Hatzitheodorou E; Varaklioti A; Karafoulidou A; Hatzitaki M; Kavallierou L; Mouzaki A; Andrioti E; Veneti C; Kaperoni A; Zervou E; Politis C; Hatzakis A
J Med Virol; 2009 May; 81(5):815-25. PubMed ID: 19319945
[TBL] [Abstract][Full Text] [Related]
63. Molecular epidemiology of hepatitis delta virus (HDV) in Iran: a preliminary report.
Mohebbi SR; Zali N; Derakhshan F; Tahami A; Mashayekhi R; Amini-Bavil-Olyaee S; Zali MR
J Med Virol; 2008 Dec; 80(12):2092-9. PubMed ID: 19040284
[TBL] [Abstract][Full Text] [Related]
64. A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus.
Chouteau P; Le Seyec J; Cannie I; Nassal M; Guguen-Guillouzo C; Gripon P
J Virol; 2001 Dec; 75(23):11565-72. PubMed ID: 11689638
[TBL] [Abstract][Full Text] [Related]
65. Virus entry mediated by hepatitis B virus envelope proteins.
Taylor JM
World J Gastroenterol; 2013 Oct; 19(40):6730-4. PubMed ID: 24187448
[TBL] [Abstract][Full Text] [Related]
66. Prevalence of occult hepatitis B virus infection in a general adult population in Korea.
Song EY; Yun YM; Park MH; Seo DH
Intervirology; 2009; 52(2):57-62. PubMed ID: 19401629
[TBL] [Abstract][Full Text] [Related]
67. [Evaluation and clinical significance of HBV large protein (LHBs) in diagnosis of hepatitis B].
Chen YJ; Zhou YL; Xia J; Xia WW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):241-3. PubMed ID: 17971933
[TBL] [Abstract][Full Text] [Related]
68. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C
Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
[TBL] [Abstract][Full Text] [Related]
69. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
[TBL] [Abstract][Full Text] [Related]
70. Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. I. Region S(139-147).
Neurath AR; Pride MW; Strick N; Thanavala YM
Pept Res; 1991; 4(3):199. PubMed ID: 1823191
[No Abstract] [Full Text] [Related]
71. Molecular characterization of hepatitis B virus (HBV) isolates, including identification of a novel recombinant, in patients with acute HBV infection attending an Irish hospital.
Laoi BN; Crowley B
J Med Virol; 2008 Sep; 80(9):1554-64. PubMed ID: 18649329
[TBL] [Abstract][Full Text] [Related]
72. Engineered bio-nanocapsules, the selective vector for drug delivery system.
Yu D; Fukuda T; Tuoya ; Kuroda S; Tanizawa K; Kondo A; Ueda M; Yamada T; Tada H; Seno M
IUBMB Life; 2006 Jan; 58(1):1-6. PubMed ID: 16596748
[TBL] [Abstract][Full Text] [Related]
73. RNA recombination in hepatitis delta virus: implications regarding the abilities of mammalian RNA polymerases.
Chao M
Virus Res; 2007 Aug; 127(2):208-15. PubMed ID: 17296240
[TBL] [Abstract][Full Text] [Related]
74. Analysis of hepatitis B virus in the cerumen and otorrhea of chronic HBV-infected patients: is there a hepatitis B virus infectivity?
Goh EK; Son BH; Kong SK; Chon KM; Cho KS
Otol Neurotol; 2008 Oct; 29(7):929-32. PubMed ID: 18665006
[TBL] [Abstract][Full Text] [Related]
75. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan.
Mu SC; Lin YM; Jow GM; Chen BF
J Hepatol; 2009 Feb; 50(2):264-72. PubMed ID: 19070923
[TBL] [Abstract][Full Text] [Related]
76. Characteristics of lamivudine-resistant hepatitis B virus (HBV) strains with and without breakthrough hepatitis in patients with chronic hepatitis B evaluated by serial HBV full-genome sequences.
Horiike N; Duong TN; Michitaka K; Joko K; Hiasa Y; Konishi I; Yano M; Onji M
J Med Virol; 2007 Jul; 79(7):911-8. PubMed ID: 17516520
[TBL] [Abstract][Full Text] [Related]
77. Synergistic effect of radiation and interleukin-6 on hepatitis B virus reactivation in liver through STAT3 signaling pathway.
Chou CH; Chen PJ; Jeng YM; Cheng AL; Huang LR; Cheng JC
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1545-52. PubMed ID: 19327909
[TBL] [Abstract][Full Text] [Related]
78. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
Miyagawa M; Minami M; Fujii K; Sendo R; Mori K; Shimizu D; Nakajima T; Yasui K; Itoh Y; Taniwaki M; Okanoue T; Yoshikawa T
J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
[TBL] [Abstract][Full Text] [Related]
79. Redirecting retroviral tropism by insertion of hepatitis B virus PreS1 core peptide into the envelope.
Qi P; Han JX; Lu YQ; Wang CX
Arch Virol; 2007; 152(9):1721-30. PubMed ID: 17520321
[TBL] [Abstract][Full Text] [Related]
80. Role for calnexin and N-linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles.
Werr M; Prange R
J Virol; 1998 Jan; 72(1):778-82. PubMed ID: 9420286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
